YALETOWN VENTURES II LIMITED PARTNERSHIP – EARLY WARNING REPORT
#510 – 1122 Mainland Street
Vancouver, British Columbia
Vancouver, B.C., September 29, 2017 – Yaletown Ventures II Limited Partnership (“Yaletown”) reports that it has acquired a total of 4,169,500 common shares ( “Common Shares”) in the capital of Solegear Bioplastic Technologies Inc. (the “Issuer”) by way of a private transaction, at a deemed price of $0.10 per share.
The Common Shares acquired by Yaletown represent approximately 5% of the issued and outstanding Common Shares of the Issuer. Prior to the transaction, Yaletown had ownership and control over 20,293,988 Common Shares, representing approximately 27% of the issued and outstanding Common Shares. Following the transaction, Yaletown has ownership and control over 24,463,488 Common Shares, representing approximately 33% of the issued and outstanding Common Shares.
Yaletown acquired the shares as an equity investment in the Issuer. The Common Shares were acquired by private agreement from one person, and the consideration paid was not more than 115% of the market price as determined under applicable securities legislation.
Yaletown’s head office is located at #510 – 1100 Mainland Street, Vancouver, BC V6B 5L1.
For further information, or to obtain a copy of the acquisition report filed under securities legislation, please contact Mr. Hans Knapp, Director, at 604-688-7807.